MORGAN STANLEY PLC/PUT/PFIZER INC/27.5/0.1/21.03.25 Stock

Warrant

DE000MB6EZ23

Market Closed - Börse Stuttgart 15:20:12 2024-07-03 EDT
0.222 EUR +0.91% Intraday chart for MORGAN STANLEY PLC/PUT/PFIZER INC/27.5/0.1/21.03.25
Current month+2.30%
1 month+26.14%
Date Price Change
24-07-03 0.222 +0.91%
24-07-02 0.22 +7.32%
24-07-01 0.205 -5.53%
24-06-28 0.217 -7.66%
24-06-27 0.235 -2.08%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 03:20 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN MB6EZ2
ISINDE000MB6EZ23
Date issued 2023-05-22
Strike 27.5 $
Maturity 2025-03-21 (261 Days)
Parity 10 : 1
Emission price 0.19
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.38
Lowest since issue 0.095
Delta-0.44x
Omega 5.128
Premium9.25x
Gearing11.73x
Moneyness 0.9928
Difference Strike -0.2 $
Difference Strike %-0.73%
Spread 0.004
Spread %1.81%
Theoretical value 0.2190
Implied Volatility 26.46 %
Total Loss Probability 45.71 %
Intrinsic value 0.000000
Present value 0.2190
Break even 25.14 €
Theta-0x
Vega0.01x
Rho-0.01x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus